These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18493315)

  • 1. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.
    Jakobsdottir J; Conley YP; Weeks DE; Ferrell RE; Gorin MB
    PLoS One; 2008 May; 3(5):e2199. PubMed ID: 18493315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
    Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration.
    McKay GJ; Silvestri G; Patterson CC; Hogg RE; Chakravarthy U; Hughes AE
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):533-9. PubMed ID: 18806297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.
    Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z
    Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration.
    Kaur I; Katta S; Reddy RK; Narayanan R; Mathai A; Majji AB; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):59-63. PubMed ID: 19696172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration.
    Seitsonen SP; Onkamo P; Peng G; Xiong M; Tommila PV; Ranta PH; Holopainen JM; Moilanen JA; Palosaari T; Kaarniranta K; Meri S; Immonen IR; Järvelä IE
    PLoS One; 2008; 3(12):e3833. PubMed ID: 19048105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilocus analysis of age-related macular degeneration.
    Bergeron-Sawitzke J; Gold B; Olsh A; Schlotterbeck S; Lemon K; Visvanathan K; Allikmets R; Dean M
    Eur J Hum Genet; 2009 Sep; 17(9):1190-9. PubMed ID: 19259132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis.
    Lu F; Liu S; Hao Q; Liu L; Zhang J; Chen X; Hu W; Huang P
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):526-540. PubMed ID: 30179527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population.
    Kim SJ; Lee SJ; Kim NR; Chin HS
    Exp Eye Res; 2012 Mar; 96(1):42-7. PubMed ID: 22273503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
    Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
    BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.
    Wu L; Tao Q; Chen W; Wang Z; Song Y; Sheng S; Li P; Zhou J
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):170-4. PubMed ID: 23233260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.